Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
18 pending office actions • 18 clients • 18 examiners • 16 art units • 0 of 18 (0%) have an AI response strategy ready
EVENTIDE LAW LLC has handled 362 career applications in the Biotechnology & Pharmaceuticals technology area. The firm has achieved a resolved allowance rate of 88.02 percent for these matters, indicating its success in moving applications toward grant. This performance metric provides a benchmark for evaluating the firm's effectiveness in this sector.
Prosecution at the firm requires an average of 3.53 office actions per allowance. Currently, EVENTIDE LAW LLC is managing 15 pending office actions, which reflects its active workload in Biotechnology & Pharmaceuticals relative to its 362 career applications. This information provides a snapshot of the firm's historical success and current administrative status for practitioners assessing its services.
Based on the USPTO statutory response window for each pending office action. 4 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 4 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 1 (6%) |
| §101 + other | 1 (6%) |
| §103 only | 4 (22%) |
| §112 only | 1 (6%) |
| Double-patenting only | 1 (6%) |
| Double-patenting + other | 3 (17%) |
| Multi-statute (no §101) | 7 (39%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| GINES, GEORGE SAMUEL | 1 | 69.5% | +40.5% |
| RESTAINO, ANDREW PETER | 1 | 72.5% | +39.5% |
| OGLES, MATTHEW ERIC | 1 | 50.0% | +57.0% |
| KIRSCH, ANDREW THOMAS | 1 | 50.6% | +34.4% |
| RADOSAVLJEVIC, ALEKSANDAR | 1 | 81.7% | +8.7% |
| PINDERSKI, JACQUELINE M | 1 | 26.9% | +45.3% |
| CRUM, MARY ABOU NADER | 1 | 40.4% | +65.0% |
| ABBAS, ABDULRAHMAN MUSTAFA | 1 | 52.4% | +34.8% |
| SYLVESTER, KEVIN | 1 | 47.5% | +27.4% |
| ROGERS, JAMES WILLIAM | 1 | 46.2% | +22.3% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18821276 | GENETICALLY ENGINEERED LAND PLANTS THAT EXPRESS AN INCREASED SEED YIELD PROTEIN AND/OR AN INCREASED SEED YIELD RNA | RADOSAVLJEVIC, ALEKSANDAR | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18257041 | ELASTOMERIC BIOMATERIALS AND THEIR MANUFACTURE | HEINCER, LIAM J | 16d overdue |
| 19481759 | FOAM MATTRESS COMPRISING AN UPPER BODY SLIDINGLY ARRANGED OVER A LOWER BODY AND FURTHER ARRANGED WITH INSERTS | GINES, GEORGE SAMUEL | — |
| 18862361 | HOOK AND OCCLUSION DEVICE | RESTAINO, ANDREW PETER | — |
| 18851212 | METHOD OF PREVENTING OVERTRAINING, OR DETERMINING THE APPROPRIATE AMOUNT OF EXERCISE | OGLES, MATTHEW ERIC | — |
| 18892932 | Container for Storing, Transporting and Dispensing a Beverage | KIRSCH, ANDREW THOMAS | — |
| 18809819 | NASAL TUBE DEVICES FOR SECURING A NASAL TUBE AND ONE OR MORE OTHER TUBES TO A NOSE OF A PATIENT | PINDERSKI, JACQUELINE M | — |
| 18724381 | C-NUCLEOSIDE MONOPHOSPHATE SYNTHESIS | CRUM, MARY ABOU NADER | — |
| 18554513 | PURIFICATION OF PROTEINS | NOAKES, SUZANNE MARIE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18709382 | OIL-BASED SOLID COMPOSITION FOR EXTERNAL USE | ABBAS, ABDULRAHMAN MUSTAFA | 39d |
| 19481759 | FOAM MATTRESS COMPRISING AN UPPER BODY SLIDINGLY ARRANGED OVER A LOWER BODY AND FURTHER ARRANGED WITH INSERTS | GINES, GEORGE SAMUEL | — |
| 18862361 | HOOK AND OCCLUSION DEVICE | RESTAINO, ANDREW PETER | — |
| 18851212 | METHOD OF PREVENTING OVERTRAINING, OR DETERMINING THE APPROPRIATE AMOUNT OF EXERCISE | OGLES, MATTHEW ERIC | — |
| 18892932 | Container for Storing, Transporting and Dispensing a Beverage | KIRSCH, ANDREW THOMAS | — |
| 18809819 | NASAL TUBE DEVICES FOR SECURING A NASAL TUBE AND ONE OR MORE OTHER TUBES TO A NOSE OF A PATIENT | PINDERSKI, JACQUELINE M | — |
| 18724381 | C-NUCLEOSIDE MONOPHOSPHATE SYNTHESIS | CRUM, MARY ABOU NADER | — |
| 18569962 | ELECTRODE FOR INDUSTRIAL ELECTROLYSIS PROCESS | SYLVESTER, KEVIN | — |
| Art Unit | Apps |
|---|---|
| 3673 | 1 |
| 3771 | 1 |
| 3796 | 1 |
| 3733 | 1 |
| 1662 | 1 |
| 1657 | 1 |
| 1612 | 1 |
| 1618 | 1 |
| 1623 | 1 |
| 1633 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 19481759 | FOAM MATTRESS COMPRISING AN UPPER BODY SLIDINGLY ARRANGED OVER A LOWER BODY AND FURTHER ARRANGED WITH INSERTS | Care Of Sweden AB | GINES, GEORGE SAMUEL | 3673 | §102§103 | Non-Final OA | — | Pending | Nov 05, 2025 |
| 18862361 | HOOK AND OCCLUSION DEVICE | Shanghai Shape Memory Alloy Co., Ltd. | RESTAINO, ANDREW PETER | 3771 | §102§103§112 | Non-Final OA | — | Pending | Nov 01, 2024 |
| 18851212 | METHOD OF PREVENTING OVERTRAINING, OR DETERMINING THE APPROPRIATE AMOUNT OF EXERCISE | Svexa Inc. | OGLES, MATTHEW ERIC | 3796 | §101§103§112 | Non-Final OA | — | Pending | Sep 26, 2024 |
| 18892932 | Container for Storing, Transporting and Dispensing a Beverage | The Square Keg LLC | KIRSCH, ANDREW THOMAS | 3733 | §102§103 | Final Rejection | — | Pending | Sep 23, 2024 |
| 18821276 | GENETICALLY ENGINEERED LAND PLANTS THAT EXPRESS AN INCREASED SEED YIELD PROTEIN AND/OR AN INCREASED SEED YIELD RNA | Nuseed Nutritional US Inc. | RADOSAVLJEVIC, ALEKSANDAR | 1662 | DP | Non-Final OA | — | Pending | Aug 30, 2024 |
| 18809819 | NASAL TUBE DEVICES FOR SECURING A NASAL TUBE AND ONE OR MORE OTHER TUBES TO A NOSE OF A PATIENT | Applied Medical Technology, Inc. | PINDERSKI, JACQUELINE M | §103§112 | Non-Final OA | — | Pending | Aug 20, 2024 | |
| 18724381 | C-NUCLEOSIDE MONOPHOSPHATE SYNTHESIS | Enginzyme AB | CRUM, MARY ABOU NADER | 1657 | §103§112 | Non-Final OA | — | Pending | Jun 26, 2024 |
| 18709382 | OIL-BASED SOLID COMPOSITION FOR EXTERNAL USE | Rohto Pharmaceutical Co., Ltd. | ABBAS, ABDULRAHMAN MUSTAFA | 1612 | §103 | Final Rejection | 39d | Pending | May 10, 2024 |
| 18569962 | ELECTRODE FOR INDUSTRIAL ELECTROLYSIS PROCESS | De Nora Permelec Ltd. | SYLVESTER, KEVIN | §103 | Non-Final OA | — | Pending | Dec 13, 2023 | |
| 18563110 | BORONO-PHENYLALANINE DERIVATIVE | Stella Pharma Corporation | ROGERS, JAMES WILLIAM | 1618 | §103 | Non-Final OA | — | Pending | Nov 21, 2023 |
| 18561108 | OIL-IN-WATER EMULSION OF 6-ETHOXY-7-METHOXY-2-(2-METHYLSULFANYLPHENYL)-3,L-BENZOXAZIN-4-ONE | Sixera Pharma AB | BAUER, BRIANNA LEE | 1623 | §103§112DPOther | Non-Final OA | 76d | Pending | Nov 15, 2023 |
| 18554581 | EXTRACELLULAR VESICLES FROM MESENCHYMAL STROMAL CELLS FOR TREATMENT OF DISEASES | Avulotion AB | LARA, CAROLINE MONSERRAT | 1633 | §103DP | Final Rejection | — | Pending | Oct 09, 2023 |
| 18554513 | PURIFICATION OF PROTEINS | Dermapharm Aktiengesellschaft | NOAKES, SUZANNE MARIE | 1656 | §103§112 | Non-Final OA | — | Pending | Oct 09, 2023 |
| 18264486 | HUMAN CD33 ANTIBODY AND USE THEREOF | Hainan Simcere Zaiming Pharmaceutical Co., Ltd. | SCHWECHTER, BRANDON ROSS | 1674 | §112 | Non-Final OA | — | Pending | Aug 07, 2023 |
| 18257041 | ELASTOMERIC BIOMATERIALS AND THEIR MANUFACTURE | Reselo AB | HEINCER, LIAM J | 1767 | §102§103 | Final Rejection | 16d overdue | Pending | Jun 12, 2023 |
| 18325749 | Plants with Modified Deoxyhypusine Synthase Genes | Agribody Technologies, LLC | KINGDON, CATHY | 1663 | §103§112DP | Final Rejection | — | Pending | May 30, 2023 |
| 18254530 | PREDICTIVE IN VITRO ASSAY MIMICKING IN VIVO PHARMACOLOGY | Mimi-Q GmbH | DUNN, MCKENZIE A | 1686 | §101 | Non-Final OA | — | Pending | May 25, 2023 |
| 17753498 | IMPLANT FOR ATTACHING A TENDON OR A LIGAMENT TO A HARD TISSUE | Alps Holding LLC | BLASS, PARIS MARIE | 3774 | §103 | Non-Final OA | 223d overdue | Pending | Mar 04, 2022 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial